Wildlife Pharmaceuticals conducts more research, this time on the leopard

HESC_Research_BAM_Leopard_Apr16_2 (1)
In February 2016, Dr Cobus Raath and his team from Wildlife Pharmaceuticals visited HESC to conduct research aimed at better understanding the anaesthesia of cheetahs by using a combination drug known as BAM (Butorphanol / Azaperone / Medetomidine).
A week ago Wildlife Pharmaceuticals returned to the centre to conduct further research, but this time their focus was on the leopard species. The research followed the same process as the previous procedures conducted on the cheetahs. Wildlife Pharmaceuticals sent the following letter to express their gratitude to HESC for partaking in the study:
“On behalf of Wildlife Pharmaceuticals (Pty) Ltd., we would again like to give our sincerest thanks for allowing us to work with your animals and for allowing us the use of your facilities. It has been such a pleasure working with Dr Rogers and the staff at HESC and we sincerely appreciate everyone’s enthusiasm towards our research. Again, thank you for your interest and invaluable contribution toward this project. Without HESC, this research would not have been possible.
HESC_Research_BAM_Leopard_Apr16_1 (1)
The use of BAM (butorphanol, azaperone and medetomidine) appeared to be a great success in the leopard too, and we hope to continue our research into the use of this combination drug in this species. In addition, we hope to, at a minimum, publish a short communication from the data we have collected and will make sure to give special thanks to HESC for their contribution to the study.” 
In view of the immense benefit such research has for wildlife conservation, we are always proud to be able to assist with such initiatives.